These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 21245936)
1. Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma. Ou WB; Hubert C; Corson JM; Bueno R; Flynn DL; Sugarbaker DJ; Fletcher JA Neoplasia; 2011 Jan; 13(1):12-22. PubMed ID: 21245936 [TBL] [Abstract][Full Text] [Related]
2. Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation. Jiao Y; Ou W; Meng F; Zhou H; Wang A Mol Cancer; 2011 Sep; 10():125. PubMed ID: 21962244 [TBL] [Abstract][Full Text] [Related]
3. Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy. Brevet M; Shimizu S; Bott MJ; Shukla N; Zhou Q; Olshen AB; Rusch V; Ladanyi M J Thorac Oncol; 2011 May; 6(5):864-74. PubMed ID: 21774103 [TBL] [Abstract][Full Text] [Related]
4. Cancer cells harboring MET gene amplification activate alternative signaling pathways to escape MET inhibition but remain sensitive to Hsp90 inhibitors. Cell Cycle; ; . PubMed ID: 19502802 [TBL] [Abstract][Full Text] [Related]